chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body aches) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 026L20A) for COVID-19 vaccination. The patient's past medical history included Anxiety in 1999, Depression in 1999 and Clot blood (Blood clot history (DVT+PE's)) in October 2003. Concurrent medical conditions included Fruit allergy (Kiwi), Latex allergy, Drug allergy (Morphine), Asthma since October 2003, Fruit allergy (Mango), Food allergy (Bell papers), Allergy to antibiotic (Erythromycin) and Contrast media allergy (CT contrast dye). Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for Anxiety and Depression, MONTELUKAST SODIUM (SINGULAIR) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, WARFARIN for Thrombus, PROBIOTICS NOS for an unknown indication. On 05-Jan-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 4:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021 at 8:30 PM, the patient experienced CHILLS (Chills), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) on 03-Feb-2021 at an unspecified dose and frequency. On 05-Feb-2021, CHILLS (Chills), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 101.9 (High) Fever of 101.9. Patient reported 4 weeks of heart bounding, racing, beating irratically medical history which was started on 03 DEC 2020 and it is ongoing. Protandim supplement is the concomitant product used for unknown condition started on Jan2014. Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Follow up received 09apr2021, they provide 2nd dose information and patient medical history and concomitant drugs are provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This spontaneous case was reported by an other health care professional and describes the occurrence of TINNITUS (Tinnitus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This spontaneous case was reported by an other health care professional and describes the occurrence of TINNITUS (Tinnitus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Pyrexia
Clinical narrative: began to get very ill; Headache; Fever; Chills; This spontaneous case was reported by an other health professional and describes the occurrence of MALAISE (began to get very ill), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: BOTOX COSMETIC on 11-Nov-2020 and BOTOX COSMETIC on 24-Feb-2021.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced MALAISE (began to get very ill), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, MALAISE (began to get very ill), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient received his 1st dose of the vaccine on 16Mar2021. 16 hours after, the patient began to get very ill, headache, fever and chills for 12 hours.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive covid) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history ).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive covid). At the time of the report, SARS-COV-2 TEST POSITIVE (positive covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Coronavirus test
Clinical narrative: could no longer smell; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (could no longer smell) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced ANOSMIA (could no longer smell). At the time of the report, ANOSMIA (could no longer smell) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Coronavirus test: Negative.         Concomitant medication were not reported. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Fatigue; Headache; Muscle Pain; Joint Pain; Nausea; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Was forced to stay in bed for 6 weeks with "all of the typical symptoms".).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) had resolved.            Patient stated that he was "down for two days" and no side effects were present at that time.   This case was linked to MOD-2021-074454 (Patient Link).   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fatigue; Headache; Muscle Pain; Joint Pain; Nausea; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Was forced to stay in bed for 6 weeks with "all of the typical symptoms".).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) had resolved.            Patient stated that he was "down for two days" and no side effects were present at that time.   This case was linked to MOD-2021-074454 (Patient Link).   Reporter did not allow further contact
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Wooziness; Lightheadedness; Lightheadedness occurs more when has reading glasses on; Feels "off" when exerting energy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Wooziness), DIZZINESS (Lightheadedness), DIZZINESS (Lightheadedness occurs more when has reading glasses on) and FEELING ABNORMAL (Feels "off" when exerting energy) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (Wooziness), DIZZINESS (Lightheadedness), DIZZINESS (Lightheadedness occurs more when has reading glasses on) and FEELING ABNORMAL (Feels "off" when exerting energy). At the time of the report, DIZZINESS (Wooziness), DIZZINESS (Lightheadedness), DIZZINESS (Lightheadedness occurs more when has reading glasses on) and FEELING ABNORMAL (Feels "off" when exerting energy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Headache, Rash, Vaccination site pain
Clinical narrative: Rash all over her torso; A red streak appeared all down her arm; Itching at the injection site/itchy arm; Headache; Chills; Pain at the injection site/ sore; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (Rash all over her torso), ERYTHEMA (A red streak appeared all down her arm), VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm), HEADACHE (Headache) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm), HEADACHE (Headache), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at the injection site/ sore). On 08-Apr-2021, the patient experienced RASH (Rash all over her torso) and ERYTHEMA (A red streak appeared all down her arm). On 08-Apr-2021, HEADACHE (Headache) and CHILLS (Chills) had resolved. On 10-Apr-2021, RASH (Rash all over her torso) and ERYTHEMA (A red streak appeared all down her arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm) and VACCINATION SITE PAIN (Pain at the injection site/ sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Rash all over her torso; A red streak appeared all down her arm; Itching at the injection site/itchy arm; Headache; Chills; Pain at the injection site/ sore; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (Rash all over her torso), ERYTHEMA (A red streak appeared all down her arm), VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm), HEADACHE (Headache) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm), HEADACHE (Headache), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at the injection site/ sore). On 08-Apr-2021, the patient experienced RASH (Rash all over her torso) and ERYTHEMA (A red streak appeared all down her arm). On 08-Apr-2021, HEADACHE (Headache) and CHILLS (Chills) had resolved. On 10-Apr-2021, RASH (Rash all over her torso) and ERYTHEMA (A red streak appeared all down her arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site/itchy arm) and VACCINATION SITE PAIN (Pain at the injection site/ sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vertigo
Clinical narrative: Sore arm; Vertigo / side effect caller was having were related to vertigo; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO, DIZZINESS, and PAIN IN EXTREMITY in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VERTIGO and DIZZINESS. On an unknown date, the patient experienced PAIN IN EXTREMITY. At the time of the report, VERTIGO, DIZZINESS, and PAIN IN EXTREMITY outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was provided as MECLOZINE HYDROCHLORIDE.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Significant follow up received. The side effects caller was having were related to vertigo. There is no connection of side effects with vaccine
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site erythema
Clinical narrative: fatigue; headache; muscle pain; joint pain; chills; nausea; vomiting; Injection site red; injection site swollen; injection site itching; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), INJECTION SITE ERYTHEMA (Injection site red), INJECTION SITE SWELLING (injection site swollen) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), INJECTION SITE ERYTHEMA (Injection site red), INJECTION SITE SWELLING (injection site swollen) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Updated Patient demographic details and AE Onset date
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Myalgia, Nausea, Vomiting
Clinical narrative: fatigue; headache; muscle pain; joint pain; chills; nausea; vomiting; Injection site red; injection site swollen; injection site itching; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), INJECTION SITE ERYTHEMA (Injection site red), INJECTION SITE SWELLING (injection site swollen) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), INJECTION SITE ERYTHEMA (Injection site red), INJECTION SITE SWELLING (injection site swollen) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Updated Patient demographic details and AE Onset date
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: pretty Heavy period; This spontaneous case was reported by an other and describes the occurrence of HEAVY MENSTRUAL BLEEDING (pretty Heavy period) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (pretty Heavy period). At the time of the report, HEAVY MENSTRUAL BLEEDING (pretty Heavy period) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red patch on upper arm; itchy patch on upper arm; Raised rash on arms and legs, knees, waist; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (red patch on upper arm), VACCINATION SITE PRURITUS (itchy patch on upper arm) and RASH PAPULAR (Raised rash on arms and legs, knees, waist) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 39K202A and 039k202A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No medical history or conditions.). Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for Birth control.   On 30-Dec-2020 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021 at 5:06 PM, the patient experienced VACCINATION SITE ERYTHEMA (red patch on upper arm) and VACCINATION SITE PRURITUS (itchy patch on upper arm). 07-Jan-2021 at 5:06 PM, the patient experienced RASH PAPULAR (Raised rash on arms and legs, knees, waist). On 08-Jan-2021, VACCINATION SITE ERYTHEMA (red patch on upper arm), VACCINATION SITE PRURITUS (itchy patch on upper arm) and RASH PAPULAR (Raised rash on arms and legs, knees, waist) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Lo Loestrin for birth control.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever). At the time of the report, PYREXIA (Low grade fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant drugs and treatment medications were reported.   This case was linked to MOD-2021-074536 (Linked Report).; Sender's Comments:  MOD-2021-074536:Second Dose
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-074562 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074562:2nd dose
Sex: U
Vaccine: COVID19
Symptoms: Ageusia, Chills, Headache, Lethargy, Myalgia
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of Lethargy, Loss of taste, sense of smell has also acutely been effected, myalgia, and chills in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced lethargy, myalgia, chills, and headache. On 11-Apr-2021, the patient experienced loss of taste and sense of smell has also acutely been effected. At the time of the report, lethargy, myalgia, chills, and headache was resolving and loss of taste and sense of smell has also acutely been effected outcome was unknown.            Treatment information was not provided. Concomitant medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of Lethargy, Loss of taste, sense of smell has also acutely been effected, myalgia, and chills in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced lethargy, myalgia, chills, and headache. On 11-Apr-2021, the patient experienced loss of taste and sense of smell has also acutely been effected. At the time of the report, lethargy, myalgia, chills, and headache was resolving and loss of taste and sense of smell has also acutely been effected outcome was unknown.            Treatment information was not provided. Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Fatigue, Nausea, Pyrexia
Clinical narrative: Fever; nauseous; dizziness; sinus issues; fatigue; bit of cough; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues), FATIGUE (fatigue) and COUGH (bit of cough). At the time of the report, PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues), FATIGUE (fatigue) and COUGH (bit of cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to -MODERNATX, INC.-MOD-2021-074542 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-074542:1st dose
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder
Clinical narrative: Fever; nauseous; dizziness; sinus issues; fatigue; bit of cough; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues), FATIGUE (fatigue) and COUGH (bit of cough). At the time of the report, PYREXIA (Fever), NAUSEA (nauseous), DIZZINESS (dizziness), SINUS DISORDER (sinus issues), FATIGUE (fatigue) and COUGH (bit of cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to -MODERNATX, INC.-MOD-2021-074542 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-074542:1st dose
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Oropharyngeal pain, Pain, Pharyngeal swelling
Clinical narrative: Felt sick; Headache; Felt achy; Throat glands were swollen; Horrible sore throat; Voice is raspy; Itching everywhere; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen) and OROPHARYNGEAL PAIN (Horrible sore throat) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was provided.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vocal cord thickening
Clinical narrative: Felt sick; Headache; Felt achy; Throat glands were swollen; Horrible sore throat; Voice is raspy; Itching everywhere; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen) and OROPHARYNGEAL PAIN (Horrible sore throat) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was provided.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Myalgia
Clinical narrative: Thinks that liquid came out when they were administering the vaccine, so maybe didn't receive full; Only feel sore when I press the whole, not the area of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Thinks that liquid came out when they were administering the vaccine, so maybe didn't receive full) and MYALGIA (Only feel sore when I press the whole, not the area of the vaccine) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concomitant products included EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA), SIMVASTATIN, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA), OLMESARTAN, METOPROLOL and URSODIOL for an unknown indication.    On 10-Apr-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced ACCIDENTAL UNDERDOSE (Thinks that liquid came out when they were administering the vaccine, so maybe didn't receive full) and MYALGIA (Only feel sore when I press the whole, not the area of the vaccine). At the time of the report, ACCIDENTAL UNDERDOSE (Thinks that liquid came out when they were administering the vaccine, so maybe didn't receive full) and MYALGIA (Only feel sore when I press the whole, not the area of the vaccine) outcome was unknown.            Treatment medicines were  not provided Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-074611 (E2B Linked Report).; Sender's Comments:  MOD-2021-074611:first dose
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose of Moderna vaccine 8 days early; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine 8 days early) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included No adverse event.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine 8 days early). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine 8 days early) had resolved.; Sender's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot # unknown,  with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue
Clinical narrative: stomach upset; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Malignant neoplasm without specification of site (Malignant neoplasm of unspecified site of unspecified female breast.). Concomitant products included TUCATINIB (TUKYSA) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach upset) and FATIGUE (fatigue). At the time of the report, ABDOMINAL DISCOMFORT (stomach upset) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: After first short only had a little area around needle that felt sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After first short only had a little area around needle that felt sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA), SIMVASTATIN, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA), OLMESARTAN, METOPROLOL, URSODIOL and VITAMINS NOS for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (After first short only had a little area around needle that felt sore). At the time of the report, MYALGIA (After first short only had a little area around needle that felt sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphonia, Dyspnoea, Throat tightness
Clinical narrative: throat closing up; chest tightness; Her voice was very hoarse, almost a whisper; difficulty breathing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of THROAT TIGHTNESS (throat closing up), CHEST DISCOMFORT (chest tightness), DYSPHONIA (Her voice was very hoarse, almost a whisper) and DYSPNOEA (difficulty breathing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT TIGHTNESS (throat closing up), CHEST DISCOMFORT (chest tightness), DYSPHONIA (Her voice was very hoarse, almost a whisper) and DYSPNOEA (difficulty breathing). The patient was treated with EPINEPHRINE (EPIPEN) (intramuscular) at a dose of 0.3 UNK. At the time of the report, THROAT TIGHTNESS (throat closing up), CHEST DISCOMFORT (chest tightness), DYSPHONIA (Her voice was very hoarse, almost a whisper) and DYSPNOEA (difficulty breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator   Patient also reported history of allergic reactions and use of epinephrine pen of 0.3mg IM administered at approximately 1:20pm in right anterior within 1 min of Epinephrine administration. Visibly calmer. Respirations less labored and rate appeared within normal limits.   This case was linked to MOD-2021-073487 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Device connection issue, Incorrect route of product administration
Clinical narrative: thinks the vaccine was given SubQ instead of intramuscularly; some fluid leaked out down her arm after injection; some fluid leaked out down her arm after injection; This spontaneous case was reported by a physical therapist and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (thinks the vaccine was given SubQ instead of intramuscularly), ACCIDENTAL UNDERDOSE (some fluid leaked out down her arm after injection) and DEVICE CONNECTION ISSUE (some fluid leaked out down her arm after injection) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (thinks the vaccine was given SubQ instead of intramuscularly), ACCIDENTAL UNDERDOSE (some fluid leaked out down her arm after injection) and DEVICE CONNECTION ISSUE (some fluid leaked out down her arm after injection). On 12-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (thinks the vaccine was given SubQ instead of intramuscularly), ACCIDENTAL UNDERDOSE (some fluid leaked out down her arm after injection) and DEVICE CONNECTION ISSUE (some fluid leaked out down her arm after injection) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that patient had not taken any treatment steps for the second dose events.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: Feeling sick; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included TREPROSTINIL and TREPROSTINIL DIOLAMIN (ORENITRAM) for Secondary pulmonary arterial hypertension, TADALAFIL and MACITENTAN (OPSUMIT).    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MALAISE (Feeling sick) and PYREXIA (Fever). At the time of the report, MALAISE (Feeling sick) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain, Paraesthesia
Clinical narrative: pain and a tingling on her left knee -the back side- and her feet; not able to sleep; pain and a tingling on her left knee -the back side- and her feet; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pain and a tingling on her left knee -the back side- and her feet), INSOMNIA (not able to sleep) and PAIN (pain and a tingling on her left knee -the back side- and her feet) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046a21a) for COVID-19 vaccination.     No medical history reported.  Concomitant products included AMLODIPINE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PARAESTHESIA (pain and a tingling on her left knee -the back side- and her feet), INSOMNIA (not able to sleep) and PAIN (pain and a tingling on her left knee -the back side- and her feet). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (pain and a tingling on her left knee -the back side- and her feet), INSOMNIA (not able to sleep) and PAIN (pain and a tingling on her left knee -the back side- and her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Myalgia, Pyrexia
Clinical narrative: shortness of breath/someone sitting on her chest; body aches; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/someone sitting on her chest), MYALGIA (body aches), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath/someone sitting on her chest), MYALGIA (body aches), PYREXIA (fever) and CHILLS (chills). The patient was treated with DOXYCYCLINE at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath/someone sitting on her chest), MYALGIA (body aches), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Hunger, Lethargy, Pyrexia
Clinical narrative: lethargic; hungry; fever; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), HUNGER (hungry) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargic), HUNGER (hungry) and PYREXIA (fever). At the time of the report, LETHARGY (lethargic), HUNGER (hungry) and PYREXIA (fever) outcome was unknown.